Hey I am on Medial • 8m
Let's be real - Molbio's revenue chart is essentially a COVID bubble, not a sustainable growth story. Yes, they went from 51Cr to 1,272Cr, but then immediately fell back to 332Cr post-pandemic. That's a 74% revenue DROP in just two years. Their projected 1,200Cr for FY25 sounds suspiciously convenient for IPO timing - I'd be extremely skeptical of those projections. The valuation of 22,000-24,000Cr is about 20x their projected revenue, which is absurdly high for a biotech hardware company with this much volatility. For comparison, traditional medtech companies trade at 3-5x revenue. This has all the hallmarks of trying to cash in before the growth story falls apart. I'm staying far away from this one.
In God We Trust, The... • 5m
How 3 cousins from Punjab turned a ₹10 desi drink into a ₹300 Cr empire 💥" In 2017, 3 cousins from Fatehgarh, Punjab sat down with a goal: 🗣️ “Let’s make India drink its own taste again.” While MNCs pushed sugary colas, they bottled up: Zeera
See More
Entrepreneur | Build... • 3m
Lenskart: The 7-Year Struggle That Turned Into a Global Power Play Lenskart wasn’t an overnight success. In fact, they lost 7 years just trying to make it work in India. Early on, everything was tough: Getting people to buy specs online, managing of
See More
•
OpenAI • 11m
Launched in late 2024, Jarvis is that cool new kid on the block that's shaking up advertising for brands selling on Zepto. Imagine a tool so smart that it's already blasted out 15 billion ad impressions and has generated advertising revenue equivalen
See More
Download the medial app to read full posts, comements and news.